rs1443547

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004211.5(SLC6A5):​c.304G>A​(p.Gly102Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.355 in 1,604,384 control chromosomes in the GnomAD database, including 102,567 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G102G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.38 ( 11666 hom., cov: 34)
Exomes 𝑓: 0.35 ( 90901 hom. )

Consequence

SLC6A5
NM_004211.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.24

Publications

25 publications found
Variant links:
Genes affected
SLC6A5 (HGNC:11051): (solute carrier family 6 member 5) This gene encodes a sodium- and chloride-dependent glycine neurotransmitter transporter. This integral membrane glycoprotein is responsible for the clearance of extracellular glycine during glycine-mediated neurotransmission. This protein is found in glycinergic axons and maintains a high presynaptic pool of neurotransmitter at glycinergic synapses. Mutations in this gene cause hyperekplexia; a heterogenous neurological disorder characterized by exaggerated startle responses and neonatal apnea. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2016]
SLC6A5 Gene-Disease associations (from GenCC):
  • hyperekplexia 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • hereditary hyperekplexia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.0244718E-4).
BP6
Variant 11-20601429-G-A is Benign according to our data. Variant chr11-20601429-G-A is described in ClinVar as Benign. ClinVar VariationId is 304002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.463 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC6A5NM_004211.5 linkc.304G>A p.Gly102Ser missense_variant Exon 2 of 16 ENST00000525748.6 NP_004202.4 Q9Y345-1Q4VAM4Q4VAM6
SLC6A5NM_001318369.2 linkc.-260G>A 5_prime_UTR_variant Exon 2 of 15 NP_001305298.1 Q9Y345-2Q4VAM4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC6A5ENST00000525748.6 linkc.304G>A p.Gly102Ser missense_variant Exon 2 of 16 1 NM_004211.5 ENSP00000434364.2 Q9Y345-1
SLC6A5ENST00000298923.11 linkn.304G>A non_coding_transcript_exon_variant Exon 2 of 15 1 ENSP00000298923.7 J3KNC4

Frequencies

GnomAD3 genomes
AF:
0.384
AC:
58426
AN:
152068
Hom.:
11654
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.469
Gnomad AMI
AF:
0.347
Gnomad AMR
AF:
0.392
Gnomad ASJ
AF:
0.411
Gnomad EAS
AF:
0.386
Gnomad SAS
AF:
0.442
Gnomad FIN
AF:
0.265
Gnomad MID
AF:
0.414
Gnomad NFE
AF:
0.345
Gnomad OTH
AF:
0.370
GnomAD2 exomes
AF:
0.370
AC:
83572
AN:
226056
AF XY:
0.372
show subpopulations
Gnomad AFR exome
AF:
0.470
Gnomad AMR exome
AF:
0.384
Gnomad ASJ exome
AF:
0.426
Gnomad EAS exome
AF:
0.393
Gnomad FIN exome
AF:
0.266
Gnomad NFE exome
AF:
0.342
Gnomad OTH exome
AF:
0.375
GnomAD4 exome
AF:
0.352
AC:
510646
AN:
1452198
Hom.:
90901
Cov.:
61
AF XY:
0.354
AC XY:
255810
AN XY:
721666
show subpopulations
African (AFR)
AF:
0.475
AC:
15831
AN:
33332
American (AMR)
AF:
0.382
AC:
16476
AN:
43104
Ashkenazi Jewish (ASJ)
AF:
0.420
AC:
10881
AN:
25900
East Asian (EAS)
AF:
0.389
AC:
15265
AN:
39292
South Asian (SAS)
AF:
0.436
AC:
37076
AN:
85086
European-Finnish (FIN)
AF:
0.267
AC:
13887
AN:
52044
Middle Eastern (MID)
AF:
0.444
AC:
2544
AN:
5726
European-Non Finnish (NFE)
AF:
0.340
AC:
376523
AN:
1107714
Other (OTH)
AF:
0.369
AC:
22163
AN:
60000
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
21808
43616
65423
87231
109039
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12278
24556
36834
49112
61390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.384
AC:
58448
AN:
152186
Hom.:
11666
Cov.:
34
AF XY:
0.382
AC XY:
28403
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.468
AC:
19453
AN:
41530
American (AMR)
AF:
0.391
AC:
5976
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.411
AC:
1426
AN:
3472
East Asian (EAS)
AF:
0.385
AC:
1984
AN:
5154
South Asian (SAS)
AF:
0.443
AC:
2140
AN:
4828
European-Finnish (FIN)
AF:
0.265
AC:
2813
AN:
10606
Middle Eastern (MID)
AF:
0.408
AC:
119
AN:
292
European-Non Finnish (NFE)
AF:
0.345
AC:
23432
AN:
67994
Other (OTH)
AF:
0.375
AC:
789
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1883
3766
5648
7531
9414
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
554
1108
1662
2216
2770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.354
Hom.:
25770
Bravo
AF:
0.392
TwinsUK
AF:
0.342
AC:
1269
ALSPAC
AF:
0.343
AC:
1322
ESP6500AA
AF:
0.436
AC:
1916
ESP6500EA
AF:
0.335
AC:
2871
ExAC
AF:
0.350
AC:
42097
Asia WGS
AF:
0.442
AC:
1537
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hyperekplexia 3 Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hyperekplexia Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.76
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
0.014
DANN
Benign
0.86
DEOGEN2
Benign
0.014
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.062
N
LIST_S2
Benign
0.50
T
MetaRNN
Benign
0.00020
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.69
N
PhyloP100
-2.2
PrimateAI
Benign
0.45
T
PROVEAN
Benign
0.26
N
REVEL
Benign
0.049
Sift
Benign
0.72
T
Sift4G
Benign
0.33
T
Polyphen
0.0
B
Vest4
0.018
MPC
0.19
ClinPred
0.00087
T
GERP RS
-4.0
Varity_R
0.033
gMVP
0.25
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1443547; hg19: chr11-20622975; COSMIC: COSV54223257; API